Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TOXOL INVEST ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3%   Bankruptcy risk   0.7% 0.6% 0.6% 0.7% 1.0% 0.7% 7.9% 7.8%   Credit score (0-100)   96 98 97 93 87 93 31 31   Credit rating   AA AA AA AA A AA BB BB   Credit limit (kDKK)   991.9 1,412.3 2,146.9 1,973.3 1,303.8 2,057.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,225 3,316 4,568 5,029 4,647 3,903 0.0 0.0   EBITDA   2,666 2,930 4,043 3,609 3,468 2,994 0.0 0.0   EBIT   4,196 5,585 9,468 3,931 2,397 3,738 0.0 0.0   Pre-tax profit (PTP)   3,178.1 4,322.1 7,780.7 2,022.8 470.9 1,169.5 0.0 0.0   Net earnings   2,554.2 3,355.6 6,071.9 1,575.7 388.5 916.0 0.0 0.0   Pre-tax profit without non-rec. items   3,178 4,322 7,781 2,023 471 1,169 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   48,883 51,537 79,564 79,902 70,067 70,812 0.0 0.0   Shareholders equity total   8,130 11,486 17,558 19,133 19,522 20,438 20,313 20,313   Interest-bearing liabilities   31,053 29,453 49,965 51,378 42,714 42,546 0.0 0.0   Balance sheet total (assets)   49,364 52,101 79,911 83,089 72,337 72,359 20,313 20,313   Net Debt   31,048 29,446 49,961 51,184 42,386 42,542 -20,313 -20,313     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,225 3,316 4,568 5,029 4,647 3,903 0.0 0.0   Gross profit growth   5.7% 2.8% 37.8% 10.1% -7.6% -16.0% -100.0% 0.0%   Employees   2 2 2 5 4 3 0 0   Employee growth %   -33.3% 0.0% 0.0% 150.0% -20.0% -25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   49,364 52,101 79,911 83,089 72,337 72,359 20,313 20,313   Balance sheet change%   4.0% 5.5% 53.4% 4.0% -12.9% 0.0% -71.9% 0.0%   Added value   4,195.7 5,584.7 9,468.2 3,931.5 2,396.9 3,738.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,530 2,655 28,026 338 -9,835 745 -70,812 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   130.1% 168.4% 207.3% 78.2% 51.6% 95.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.7% 11.0% 14.3% 4.8% 3.2% 5.2% 0.0% 0.0%   ROI %   9.3% 11.9% 15.3% 5.3% 3.6% 5.7% 0.0% 0.0%   ROE %   37.3% 34.2% 41.8% 8.6% 2.0% 4.6% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   16.5% 22.0% 22.0% 23.0% 27.0% 28.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1,164.5% 1,005.1% 1,235.9% 1,418.3% 1,222.1% 1,421.0% 0.0% 0.0%   Gearing %   382.0% 256.4% 284.6% 268.5% 218.8% 208.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.2% 4.2% 4.3% 3.8% 4.3% 6.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.0 0.1 0.0 0.4 0.4 0.2 0.0 0.0   Current Ratio   0.0 0.1 0.0 0.4 0.4 0.2 0.0 0.0   Cash and cash equivalent   5.9 7.6 4.3 194.2 328.1 4.8 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -9,653.0 -9,548.1 -8,940.0 -4,444.7 -4,142.4 -5,445.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   2,098 2,792 4,734 786 599 1,246 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1,333 1,465 2,021 722 867 998 0 0   EBIT / employee   2,098 2,792 4,734 786 599 1,246 0 0   Net earnings / employee   1,277 1,678 3,036 315 97 305 0 0